Antiprogestin Drugs: Research and Clinical Use in Sweden

Kovacs L. Sas M. Resh B.A. Ugocsai G. Swahn M.L. Bygdeman M. and Rowe P.J. , “Termination of Early Pregnancy by RU 486—An Antiprogestational Compound”, Contraception, 29 (1984), pp. 399–410.

Bygdeman M. and Swahn M.L. , “Progesterone Receptor Blockage. Effect on Uterine Contractility and Early Pregnancy, ”Contraception, 32 (1985), pp. 45–51; Swahn M.L. and Bygdeman M. , “The Effect of the Antiprogestin RU 486 on Uterine Contractility and Sensitivity to Prostaglandin and Oxytocin”, British Journal of Obstetrics and Gynaecology, 95 (1988), pp. 126–34.

Swahn M.L. and Bygdeman M. , “Termination of Early Pregnancy with RU 486 (Mifepristone) in Combination with a Prostaglandin Analogue (Sulprostone), ”Acta Obstetricia et Gynecologica Scandinavica, 68 (1989), pp. 293–300.

Holmgren K. , “Women's Evaluation of Three Early Abortion Methods, ”Acta Obstetricia et Gynecologica Scandinavica, (submitted).

Holmgren K. , “Time of Decision to Undergo a Legal Abortion, ”Gynecologic and Obstetric Investigation, 26 (1988), pp. 289–95.

Ibid.

Gottlieb C. and Bygdeman M. , “The Use of Antiprogestin (RU 486) for Termination of Second Trimester Pregnancy, ”Acta Obstetricia et Gynecologica Scandinavica, 70 (1991), pp. 199–203; Gottlieb C. and Bygdeman M. , “Antiprogestin and Prostaglandins for Termination of Mid- and Late Second Trimester Pregnancy,”(to be published).

Rådestad A. Christensen N.J. and Strömberg L. , “Induced Cervical Ripening with Mifepristone in First Trimester Pregnancy. A Double Blind Randomized Biomechanical Study, ”Contraception, 38 (1988), pp. 301–12.

Swahn M.L. Johannisson E. Daniore V. de la Torre B. and Bygdeman M. , “The Effect of RU 486 Administered During the Proliferative and Secretory Phase of the Cycle on the Bleeding Pattern, Hormonal Parameters and the Endometrium, ”Human Reproduction, 3 (1988), pp. 915–21.

Swahn M.L. Bygdeman M. Xing S. Cekan S. Masironi B. and Johannisson E. , “The Effect of RU 486 Administered During the Early Luteal Phase on Bleeding Pattern, Hormonal Parameters and Endometrium, ”Human Reproduction, 42 (1990), pp. 402–8.

Gemzell K. Swahn M.L. and Bygdeman M. , “Regulation of Non- Pregnant Human Uterine Contractility: Effects of Anti-hormones, ”Contraception, 42 (1990), pp. 323–35.

Swahn M.L. Bygdeman M. Seppälä M. Johannisson E. and Cekan S. , “Effect of Tamoxifen Alone and in Combination with RU 486 on the Endometrium at the Time of Implantation, ”Human Reproduction, (submitted); Mäentausta O. Gemzell K. Svalander P. Bygdeman M. and Vihko R. “The Effects of an Antiprogestin, Mifepristone, and an Antiestrogen, Tamoxifen, on the Endometrial 17b-Hydroxy-Steroid-Dehydrogenase and Progesterone and Estrogen Receptors During the Luteal Phase of the Menstrual Cycle: An Immunohistochemical Study,”(to be published).

Navot D. Scott R.T. Droesch K. Veeck L.L. Liw H.C. and Rosenwakz L. , “The Window of Embryo Transfer and the Efficiency of Human Contraception in vitro, ”Fertility and Sterility, 55 (1991), pp. 114–8.

Swahn M.L. Gemzell K. and Bygdeman M. , “Contraception with Mifepristone, ”Lancet, 338 (1991), pp. 942–3.